Genetics
George W. Bush Signs H.R. 493, the Genetic Information Nondiscrimination Act of 2008
May 21, 2008 -- THE PRESIDENT: I want to thank the members of Congress who've joined us as I sign the Genetic Information Nondiscrimination Act, a piece of legislation which prohibits health insurers and employers from discriminating on the basis of genetic information. » read more »
Ted Kennedy Spokeswoman On Genetic Information Non-Discrimination Act Being Signed Into Law
May 21, 2008 -- WASHINGTON, DC — Today, the Office of Senator Edward M. Kennedy, Chairman of the Health, Education, Labor and Pensions Committee, released the following statement in response to President Bush signing the Genetic Information Non-Discrimination Act into law.
Melissa Wagoner, spokeswoman for Senator Kennedy, said, "Today, the President signed what Senator Kennedy calls the first civil rights law of the century of the life sciences. This bipartisan legislation continues Senator Kennedy's ongoing commitment to a fairer and more just America, by barring discrimination on the basis of an individual's DNA code, just as the nation has previously prohibited discrimination based on race, gender or national origin."
Source: Senator Ted Kennedy's office
Senator Hillary Clinton on Signing into Law of the Genetic Information Non-Discrimination Act
May 21, 2008 -- WASHINGTON, DC -- Senator Hillary Clinton today issued the following statement on the President’s signing into law of the Genetic Information Non-Discrimination Act.
“Today our nation has struck down a barrier that has for too long threatened the privacy and equality of many Americans. Personal genetic information will no longer stand in the way of anyone’s ability to obtain health care. The fear of discrimination must never stop people from undergoing critical tests for genetic illnesses. » read more »
Senator Ted Kennedy In Support Of Genetic Information Nondiscrimination Bill
(As Prepared for Delivery)
April 24, 2008 -- Today, the Senate is considering the first major new civil rights bill of the new century. Five years ago this week, we celebrated a milestone that once seemed unimaginable – the completion of the Human Genome Project, which sequenced and mapped all of the genes in the human body. This Friday is “DNA Day,” when we pay tribute to this amazing accomplishment, which was the dawn of a new era in the life sciences. » read more »
Statement of Senator Barack Obama on the Senate's Passage of the Genetic Information Nondiscrimination Act
April 24, 2008 -- WASHINGTON, D.C. - U.S. Senator Barack Obama today released the following statement after the Senate's passage of the Genetic Information Nondiscrimination Act (H.R. 493):
"I am proud the Senate passed landmark legislation today to protect all Americans from discrimination by insurance companies and employers on the basis of our genetics. The Genetic Information Nondiscrimination Act will strengthen our privacy and civil rights protections in this new century of medical breakthroughs.
Automated DNA analyzers: Photo by Steve Jurvetson (CC) » read more »
Gene Therapy Reduces Cocaine Use in Rats
Flooding brain with "pleasure chemical" receptors works on cocaine, as on alcohol
April 16, 2008 -- UPTON, NY - Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have shown that increasing the brain level of receptors for dopamine, a pleasure-related chemical, can reduce use of cocaine by 75 percent in rats trained to self-administer it.
Peter Thanos: Photo courtesy Brookhaven Labs » read more »
Florida Governor Crist Announces University Of Miami Human Genomic Institute
February 1, 2008 -- MIAMI – Florida Governor Charlie Crist today joined Speaker Marco Rubio and University of Miami President Donna Shalala to announce the creation of the University of Miami Human Genomics Institute.
“Today’s announcement is a testament to Florida’s success in establishing one of the top biotechnology centers in the nation,” said Governor Crist. “The Miami institute, along with Florida’s other innovative life science projects, will help medical doctors do a better job of preventing, detecting, and treating diseases.” » read more »
CDC Statement on Release of Genetic Testing Recommendations
The National Office of Public Health Genomics (NOPHG) at the Centers for Disease Control and Prevention (CDC) established the independent, non-federal Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group in 2005 to support the development of a systematic process for evaluating genetic tests in clinical practice. Reliable, evidence-based information is urgently needed by health care providers, consumers, policy makers, and others to help determine which genetic tests are safe and effective, and to provide guidance on their appropriate use. » read more »
TGen and Arizona Dept. of Health Services Receive Grant to Study Valley Fever Genome
Nov. 26, 2007 -- The Translational Genomics Research Institute (TGen) and the Arizona Department of Health Services have been awarded a highly competitive Arizona Biomedical Research Commission (ABRC) grant to study the genome of the fungus that causes Valley Fever, a respiratory illness caused by the inhalation of fungal spores that live in the soils of the desert southwest. This research will result in new analytical tools that will help determine where Valley Fever comes from, how transmission occurs, and a way to link cases to sites of exposure. » read more »
Experts Warn Gene-doping on Horizon
Urge Public to Discuss Ethical Implications
Ancient Olympians were known to seek potions from astrologers to gain victory on the athletic field. But speakers at a AAAS co-sponsored Capitol Hill briefing warned that modern-day athletes may soon look for an advantage from a different sort of potion-maker: geneticists.
By deliberately altering their genes to increase muscle mass, quickly recover from a sprint, or more efficiently use oxygen, athletes may seek to gain an edge against their opponents. » read more »
Genetically Engineered Plants Eat Toxic Waste
16 October 2007 -- Researchers have genetically engineered plants with an eye toward neutralizing toxic waste on military bases and mopping up industrial chemicals near manufacturing sites. The scientists are using the plants as a natural solution to serious environmental hazards.
It's called phyto-remediation, the use of plants to rid soil of toxic pollutants that threaten the drinking water of communities located near military or industrial sites. » read more »
USDA Concludes Genetically Engineered Rice Investigation
WASHINGTON, Oct. 5, 2007--The U.S. Department of Agriculture's Under Secretary for Marketing and Regulatory Programs Bruce Knight today announced the conclusion of the genetically engineered rice (GE) investigation. The investigation, which was conducted by USDA's Animal and Plant Health Inspection Service (APHIS) Investigative and Enforcement Services in coordination with USDA's Office of the Inspector General, focused on the unintentional release of trace amounts of regulated genetically engineered rice detected in two commercial varieties of long-grain rice. » read more »
British Scientists Highlight Benefits of Genetic Research in Sport, but Warn of Ethical Concerns
Sept. 13, 2007 -- Genetic research into athletic ability should be encouraged for its potential benefits in both sport and public health, a leading group of scientists meeting at the University of Bath said today.
However, ethical concerns, such as whether seeking information about differences between ethnic groups could be perceived as racist research, need to be properly addressed, they warn.
Their recommendations are published in a ‘position stand’ on genetic research and testing launched at the British Association of Sport & Exercise Sciences annual meeting today. » read more »
Study Identifies Genetic Risk Factor for Rheumatoid Arthritis, Lupus
Thursday, September 6, 2007 -- A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus). These research findings result from a long-time collaboration between the Intramural Research Program (IRP) of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other organizations. NIAMS is part of the National Institutes of Health.
These results appear in the Sept. 6 issue of the New England Journal of Medicine. » read more »
Genome Pioneer Venter Keynotes NYU Symposium on Momentous Impact of "Designer Microbes", Sept. 29
Friday, Aug 31, 2007 -- Famed geneticist J. Craig Venter, who mapped the human genome and now heads a global effort to create “designer microbes” to address some of the world’s most vexing global environmental and health problems, will keynote a symposium on the subject on Saturday, Sept. 29, from 2 to 4 p.m. at New York University’s Cantor Film Center (36 E. 8th St. at University Place [Subway Lines: R, W (8th Street); 6 (Astor Place)]). » read more »